Koers Genetics Generation Advancement Corp.
Aandelen
4160
TW0004160007
Biotechnologie & Medisch Onderzoek
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
50,3 TWD | -0,40% | +20,48% | +29,31% |
Omzet 2022 | 548 mln. 16,81 mln. 15,68 mln. | Omzet 2023 | 592 mln. 18,19 mln. 16,96 mln. | Marktkapitalisatie | 988 mln. 30,33 mln. 28,29 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 25 mln. 767K 716K | Nettowinst (verlies) 2023 | 28 mln. 859K 801K | EV/omzet 2022 | 0,75 x |
Nettoliquiditeiten 2022 | 255 mln. 7,83 mln. 7,3 mln. | Nettoliquiditeiten 2023 | 266 mln. 8,16 mln. 7,61 mln. | EV/omzet 2023 | 1,22 x |
K/w-verhouding 2022 |
26,1
x | K/w-verhouding 2023 |
34,7
x | Werknemers | 104 |
Dividendrendement 2022 |
1,74% | Dividendrendement 2023 |
1,31% | Vrij verhandelbaar | 58,95% |
1 dag | -0,40% | ||
1 week | +20,48% | ||
Lopende maand | +18,91% | ||
1 maand | +17,39% | ||
3 maanden | +18,63% | ||
6 maanden | +34,67% | ||
Lopend jaar | +29,31% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Cheng Hsien Tsai
CEO | Chief Executive Officer | - | - |
Tai Sheng Chang
CTO | Chief Tech/Sci/R&D Officer | - | - |
Fang Chun Huang
IRC | Investor Relations Contact | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yue Jen Huang
BRD | Director/Board Member | - | 10-06-20 |
Cheng Hsien Tsai
CEO | Chief Executive Officer | - | - |
Wen Cheng Chang
BRD | Director/Board Member | - | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 50,3 | -0,40% | 1 093 370 |
23-04-24 | 50,5 | +9,90% | 1 218 704 |
22-04-24 | 45,95 | +9,93% | 263 161 |
19-04-24 | 41,8 | 0,00% | 36 174 |
18-04-24 | 41,8 | +0,12% | 24 766 |
slotkoers Taipei Exchange, 24 april 2024
Meer koersenVaira. 1 jan. | Kapi. | |
---|---|---|
+29,31% | 39,38 mln. | |
-14,52% | 11,53 mld. | |
+44,03% | 3,31 mld. | |
-33,09% | 2,11 mld. | |
-18,60% | 2,05 mld. | |
-27,59% | 1,49 mld. | |
+17,10% | 1,02 mld. | |
-3,06% | 741 mln. | |
-33,50% | 426 mln. | |
-46,94% | 374 mln. |